Tine Bryan Stensbøl
Divisional Director for Discovery Pharmacology Research, Lundbeck
Dr Tine Bryan Stensbøl is the Divisional Director for Synaptic Transmission Research at Lundbeck.
Tine Bryan Stensbøl graduated from The University of Pharmaceutical Sciences in Copenhagen in 1993, where she continued her PhD studies in Medicinal Chemistry and Molecular Pharmacology within the glutamate field. After a post doc period at the University of Pharmaceutical Sciences, she started at Lundbeck in 2001 as a research scientist. Here she became the project lead of one of Lundbecks discovery projects in depression successfully pushing 4 compounds into development 2 of which are now in phase 2 and 3 clinical trials. Tine now directs a biology-driven focus area at Lundbeck, namely Synaptic transmission Research and is a member of the Drug Discovery Management Team responsible for the outlining as well as implementing of Lundbecks strategic research plan in DK.
Further to this she is the coordinator of apublic private partnership under the Innovative Medicines Initiatives (IMI) umbrella called NEWMEDS, focusing on addressing the major need for improved treatments for depression and schizophrenia and involves 23 partners comprising pharmaceutical companies, SMEs and leading academic institutions in Europe.